(Press-News.org) Combined treatment with a drug that mimics the action of a gut hormone and basal insulin [1] is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.
"Achieving normal blood sugar levels in people with type 2 diabetes is compromised by the adverse side effects plaguing currently available treatments. Some anti-diabetic treatments increase risk of hypoglycaemia and weight gain which put patients at increased risk of heart attack and stroke, as well as reducing their quality of life"*, explains Dr Ravi Retnakaran, lead author and endocrinologist at Mount Sinai Hospital, Toronto, Canada.
Glucagon-like peptide-1 (GLP-1) is a hormone that is secreted from the gut after eating. GLP-1 based therapy was recently introduced as a new treatment for patients with type 2 diabetes because of its ability to regulate blood sugar levels and to generate weight loss as opposed to weight gain. Moreover, GLP-1 agonists only stimulate insulin secretion when blood glucose levels are high, without increasing risk of hypoglycaemia. However, their optimal role in the management of type 2 diabetes has yet to be established.
Retnakaran and colleagues identified 2905 studies over 64 years involving basal insulin and/or GLP-1 agonists in adults with type 2 diabetes. The analysis of 15 randomised trials involving more than 4300 participants showed that the combination of basal insulin with a GLP-1 agonist resulted in a 92% greater likelihood of achieving target blood sugar control (A1c of 7% or lower [2]), with similar rates of hypoglycaemia and an average weight loss of more than 3kg compared with other anti-diabetic treatments. Compared to full basal-bolus insulin regimens [3], the combined treatment generated modestly better blood sugar control, but had a 33% lower risk of hypoglycaemia and almost 6kg greater weight loss.
According to Dr Retnakaran: "Combining a GLP-1 agonist with basal insulin is a treatment strategy that can achieve the ideal triumvirate of short-term outcomes in diabetes management: optimal glucose control alongside weight loss and a low risk of hypoglycaemic episodes. As such, this combination treatment could improve the management of people with type 2 diabetes."*
Writing in a linked Comment, Dr John Buse, Chief of the Division of Endocrinology at the University of North Carolina School of Medicine in the USA says, "Perhaps the most practical and immediate issue is whether the fixed-dose combinations of a GLP-1 agonist and basal insulin in development will supersede other approaches. This is an unsettled question, but it seems likely that fixed-dose combinations will be welcomed in view of their convenience and efficacy…The major barrier to widespread adoption of these treatments is cost—both GLP-1 agonists and insulin analogues are among the most expensive in diabetes care. One can hope that some incremental cost savings will come with combined products. It has been a 20-year journey, but the combination of GLP-1 agonist and basal insulin has finally arrived as a more powerful and safer alternative to insulin in the management of type 2 diabetes."
INFORMATION:
Notes to Editors:
[1] The role of basal insulin, also known as background insulin, is to keep blood glucose at consistent levels during periods of fasting and is taken once or twice a day.
[2]Controlling blood sugar can help prevent small blood vessel (or microvascular) complications that can lead to blindness, kidney failure, and amputations. Blood sugar control is measured using the combination of haemoglobin A1c in the blood, and concentrations less then 7% can substantially reduce the risk of these complications.
[3] A basal-bolus regimen involves taking a longer acting form of insulin to keep blood glucose levels stable through periods of fasting and separate injections of shorter-acting insulin to prevent rises in blood glucose levels at meal times.
*Quotes direct from author and cannot be found in text of Article.
The Lancet: Combining gut hormone with insulin proves more effective at controlling type 2 diabetes than other common treatments
2014-09-12
ELSE PRESS RELEASES FROM THIS DATE:
Many kidney failure patients have concerns about pursuing kidney transplantation
2014-09-12
Washington, DC (September 11, 2014) — Concerns about pursuing kidney transplantation are highly prevalent among kidney failure patients, particularly older adults and women, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). Reducing these concerns may help decrease disparities in access to transplantation.
There are thousands of patients with kidney failure who lack access to kidney transplantation, and disparities persist in terms of race, age, sex, and other patient characteristics. To improve ...
Microbes evolve faster than ocean can disperse them
2014-09-12
Two Northeastern University researchers and their international colleagues have created an advanced model aimed at exploring the role of neutral evolution in the biogeographic distribution of ocean microbes.
Their findings were published Thursday in the journal Science. The paper—titled "Biogeographic patterns in ocean microbes emerge in a neutral agent-based model"—was co-authored by Ferdi Hellweger, a microbial ecology expert and an associate professor of civil and environmental engineering; his doctoral student Neil Fredrick, PhD'15; and oceanographer Erik van Sebille ...
Inflammation may be key to diabetes/heart disease link
2014-09-11
Inflammation may be the reason high blood sugar levels damage blood vessels, raising the possibility that anti-inflammatory medications might someday be used to lower the risk of blood vessel disease in people with diabetes, according to a study presented at the American Heart Association's High Blood Pressure Research Scientific Sessions 2014.
"These findings may explain why good blood sugar control is not sufficient to avoid the development of diabetes-induced cardiovascular diseases," said Carlos F. Sánchez-Ferrer, M.D., Ph.D., study author and professor of pharmacology ...
Cutting the cord on soft robots
2014-09-11
When it comes to the development of soft robots, researchers have finally managed to cut the cord.
Engineers at Harvard's School for Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering have developed the world's first untethered soft robot – a quadruped which can literally stand up and walk away from its designers.
Working in the lab of Charles River Professor of Engineering and Applied Sciences Robert Wood, a team of researchers that included Michael Tolley, Robert Shepherd, Bobak Mosadegh, Kevin Galloway, Michael Wehner ...
NASA research helps unravel mysteries of the Venusian atmosphere
2014-09-11
VIDEO:
New research shows giant holes in Venus' atmosphere -- which serve as extra clues for understanding this planet so different from our own.
Click here for more information.
Underscoring the vast differences between Earth and its neighbor Venus, new research shows a glimpse of giant holes in the electrically charged layer of the Venusian atmosphere, called the ionosphere. The observations point to a more complicated magnetic environment than previously thought – which ...
Tipping the balance of behavior
2014-09-11
Humans with autism often show a reduced frequency of social interactions and an increased tendency to engage in repetitive solitary behaviors. Autism has also been linked to dysfunction of the amygdala, a brain structure involved in processing emotions. Now Caltech researchers have discovered antagonistic neuron populations in the mouse amygdala that control whether the animal engages in social behaviors or asocial repetitive self-grooming. This discovery may have implications for understanding neural circuit dysfunctions that underlie autism in humans.
This discovery, ...
Original northern border of Illinois was south of Chicago and Lake Michigan
2014-09-11
URBANA, Ill. – Chicago residents today might have had a Wisconsin zip code if the originally proposed northern boundary of Illinois had been approved. It was a straight line from the southernmost tip of Lake Michigan to just south of the Rock and Mississippi River confluence. University of Illinois soil scientist Ken Olson said that had the proposed northern border not been changed, the state of Illinois would have a much smaller population and footprint with the northern 51 miles of the Illinois Territory ceded to Wisconsin when it became a state in 1848.
Olson says ...
Diabetes researchers find faster way to create insulin-producing cells
2014-09-11
University of British Columbia, in collaboration with BetaLogics Venture, a division of Janssen Research & Development, LLC, has published a study highlighting a protocol to convert stem cells into insulin-producing cells. The new procedure could be an important step in the fight against Type 1 diabetes.
The protocol can turn stem cells into reliable, insulin-producing cells in about six weeks, far quicker than the four months it took using previous methods.
"We are a step closer to having an unlimited supply of insulin-producing cells to treat patents with Type ...
One-minute point-of-care anemia test shows promise in new study
2014-09-11
A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease.
The disposable self-testing device analyzes a single droplet of blood using a chemical reagent that produces visible color changes corresponding to different levels of anemia. The basic test produces results in about 60 seconds and requires no electrical power. A companion smartphone application can automatically correlate the visual results to specific blood hemoglobin ...
Meditation may mitigate migraine misery
2014-09-11
WINSTON-SALEM, N.C. – Sept. 11, 2014 – Meditation might be a path to migraine relief, according to a new study by researchers at Wake Forest Baptist Medical Center.
"Stress is a well-known trigger for headaches and research supports the general benefits of mind/body interventions for migraines, but there hasn't been much research to evaluate specific standardized meditation interventions," said Rebecca Erwin Wells, M.D., assistant professor of neurology at Wake Forest Baptist and lead author of the study published in the online edition of the journal Headache.
The study ...